MedStar Authors catalog › Details for: Large Cohort Data Based Cost-Effective Disease Prevention Design Strategy: Strong Heart Study.
Normal view MARC view ISBD view

Large Cohort Data Based Cost-Effective Disease Prevention Design Strategy: Strong Heart Study.

by Howard, Barbara V.
Citation: World Journal of Cardiovascular Diseases. 8(12):588-601, 2018 Dec..Journal: World Journal of Cardiovascular Diseases.Published: ; 2018ISSN: 2164-5329.Full author list: Wang W; Lee ET; Howard BV; Devereux R; Zhang Y; Stoner JA.UI/PMID: 30687583.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Health Research InstituteActivity type: Journal Article.Medline article type(s): Journal ArticleOnline resources: Click here to access online Digital Object Identifier: (Click here) Abbreviated citation: World J. Cardiovasc. Dis.. 8(12):588-601, 2018 Dec.Abstract: Background and Objective: A multitude of large cohort studies have collected data on incidence and covariates/risk factors of various chronic diseases. However, approaches for utilization of these large data and translation of the valuable results to inform and guide clinical disease prevention practice are not well developed. In this paper, we proposed, based on large cohort study data, a novel conceptual cost-effective disease prevention design strategy for a target group when it is not affordable to include everyone in the target group for intervention.Abstract: Methods and Results: Data from American Indian participants (n = 3516; 2056 women) aged 45 - 74 years in the Strong Heart Study, the diabetes risk prediction model from the study, a utility function, and regression models were used. A conceptual cost-effective disease prevention design strategy based on large cohort data was initiated. The application of the proposed strategy for diabetes prevention was illustrated.Abstract: Discussion: The strategy may provide reasonable solutions to address cost-effective prevention design issues. These issues include complex associations of a disease with its significant risk factors, cost-effectively selecting individuals at high risk of developing disease to undergo intervention, individual differences in health conditions, choosing intervention risk factors and setting their appropriate, attainable, gradual and adaptive goal levels for different subgroups, and assessing effectiveness of the prevention program.Abstract: Conclusions: The strategy and methods shown in the illustrative example can also be analogously adopted and applied to other diseases preventions. The proposed strategy provides a way to translate and apply epidemiological study results to clinical disease prevention practice.

Powered by Koha